Back to MW Marshall Wace, LLP

HIMS

Showing 8 of 22 quarters

Position history for MWMarshall Wace, LLP's holdings in Hims & Hers Health, Inc.

Yes. Marshall Wace holds 4,217,767 shares of HIMS (Hims & Hers Health), worth $146.2M, as of its Q2 2026 13F filing. It increased the position from 724,227 shares in Q1 2026. Marshall Wace has held HIMS since Q4 2025, across 3 quarterly 13F filings. HIMS is 0.1% of Marshall Wace's reported 13F portfolio.

Current Value

$146.2M

Current Shares

4.2M

Total Value Change

+$116.5M

Total Shares Change

+2.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.2M
+482.4%
$146.2M0.1%$34.67
58
2026-Q1
Increased
724,227
+114x
$15M0.0%$20.76
45
2025-Q4
New
6,298
-
$204,4960.0%$32.47
32
2025-Q3
Exited
0
-100.0%
$00.0%$56.72
0
2025-Q2
Decreased
105,450
-59.7%
$5.3M0.0%$49.85
0
2025-Q1
Increased
261,872
+508.6%
$7.7M0.0%$29.55
44
2024-Q4
Decreased
43,028
-97.3%
$1M0.0%$24.18
0
2024-Q3
Decreased
1.6M
-26.8%
$29.8M0.0%$17.77
0

Other major holders of HIMS: BlackRock, Inc., Vanguard Group Inc., Capital World Investors, JPMorgan Chase & Co.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used